https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-05-19 / Radiother Oncol 2015 Nov;117(2):217-22
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-05-19 / Radiother Oncol 2015 Nov;117(2):217-222015-05-19 00:00:002015-05-19 00:00:00Local control rate after the combination of re-irradiation and hyperthermia for irresectable recurrent breast cancer: Results in 248 patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-05-18 / BJU Int. 2015 Sep;116(3):321-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-05-18 / BJU Int. 2015 Sep;116(3):321-92015-05-18 00:00:002019-02-15 08:45:12Advances in the understanding of cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-05-16 / Pharmacol. Ther. 2015 Sep;153:1-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-05-16 / Pharmacol. Ther. 2015 Sep;153:1-92015-05-16 00:00:002019-02-15 08:35:17Vaccine immunotherapy in lung cancer: Clinical experience and future directions
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-05-15 / Int J Hyperthermia 2015;31(6):609-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-05-15 / Int J Hyperthermia 2015;31(6):609-142015-05-15 00:00:002019-02-15 09:18:00Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-05-07 / Cell Death Dis 2015 May;6:e1758
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-05-07 / Cell Death Dis 2015 May;6:e17582015-05-07 00:00:002019-02-15 09:22:47IPS-1 differentially induces TRAIL, BCL2, BIRC3 and PRKCE in type I interferons-dependent and -independent anticancer activity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-05-01 / Cell Oncol (Dordr) 2015 Aug;38(4):279-88
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-05-01 / Cell Oncol (Dordr) 2015 Aug;38(4):279-882015-05-01 00:00:002015-05-01 00:00:00Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-κB/IκBα pathway
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-05-01 / J. Immunother. 2015 May;38(4):155-64
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-05-01 / J. Immunother. 2015 May;38(4):155-642015-05-01 00:00:002019-02-15 08:45:07Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors
